Skip to main content
INNOVATE Corp. logo

INNOVATE Corp. — Investor Relations & Filings

Ticker · VATE ISIN · US45784J1051 LEI · 549300S6O246JWQQ1K58 US Financial and insurance activities
Open in API
Filings indexed 1,196 across all filing types
Latest filing 2016-04-21 Proxy Solicitation & In…
Country US United States of America
Listing US VATE

About INNOVATE Corp.

https://innovatecorp.com/

INNOVATE Corp. is a diversified holding company that acquires and manages a portfolio of assets across three primary sectors: Infrastructure, Life Sciences, and Spectrum. The Infrastructure segment, through its subsidiary DBM Global, is a provider of structural steel and industrial construction services. The Life Sciences portfolio focuses on developing innovative healthcare technologies and includes companies such as Pansend Life Sciences, R2 Technologies, which markets an aesthetic dermatology device, and MediBeacon, which has developed a system for assessing kidney function. The Spectrum segment operates through HC2 Broadcasting, a large group of broadcast television stations.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It is labeled as Definitive Additional Materials related to a proxy solicitation. Proxy Statements and related materials are used to provide information to shareholders to solicit their votes for meetings. This matches the definition of Proxy Solicitation & Information Statement (PSI). The document length is short and it is not a full report but rather proxy materials. Therefore, the correct classification is PSI.
2016-04-21 English
SCHEDULE 14A
Proxy Solicitation & Information Statement
2016-04-21 English
PHILIP A. FALCONE SC 13DA NO 15 4-14-2016 (HC2 HOLDINGS, INC)
Major Shareholding Notification
2016-04-18 English
FORM 4
Director's Dealing
2016-04-18 English
FORM 3
Director's Dealing
2016-04-14 English
HC2 HOLDINGS, INC. 8-K 4-14-2016
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically discusses a change related to executive compensation arrangements, including the waiver and cancellation of anti-dilution protection provisions for stock options granted to an executive, and the grant of new stock options with specific terms. This type of disclosure fits the category of management or board changes or arrangements related to executives. The key item cited is Item 5.02, which relates to departure or appointment of directors or officers and compensatory arrangements. Therefore, this document is best classified as Board/Management Information (MANG). The document length and detail confirm it is not a brief announcement or a regulatory filing fallback. Confidence is high due to the clear SEC form type and content focus on executive compensation changes.
2016-04-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.